½Å¾à°³¹ß¿¬±¸Á¶ÇÕ(ÀÌ»çÀå ±èµ¿¿¬)ÀÌ Á¦¾à »ê¾÷°è¿Í À¯±âÇÕ¼ºÇа谣ÀÇ ½Å¾à°³¹ß ³×Æ®¿öÅ© ±¸ÃàÀÇ ÀåÀ» ¸¶·ÃÇϱâ À§ÇÑ ÀÏȯÀ¸·Î ¿À´Â 22ÀÏ~23ÀÏ ÀÌƲ°£ õ¾È »ó·Ï¸®Á¶Æ®¿¡¼ Çѱ¹À¯±âÇÕ¼ºÇÐȸ(ȸÀå õ¹®¿ì)°¡ ÁÖÃÖÇϴ“2013³â Çѱ¹À¯±âÇÕ¼ºÇÐȸ ¿öÅ©¼¥”À» ÈÄ¿ø, °³ÃÖÇÑ´Ù.
Á¶ÇÕ ¿©Àçõ »ó¹«ÀÌ»ç´Â “À̹ø ¿öÅ©¼¥¿¡¼± Çѱ¹½Å¾à°³¹ß¿¬±¸Á¶ÇÕ ¿ø·áÀǾàÇ°°³¹ß¿¬±¸È¸¿Í Çѱ¹À¯±âÇÕ¼ºÇÐȸ°¡ ÇÔ²² ¿ø·á¾àÀÇ »ê¾÷È(±¹Àü¾àÇ° ¹Ú±ÔÁ¾ ¹Ú»ç), ½Å¾à ½´ÆåÆ®ÀÇ °³¹ß(ÀϾç¾àÇ° ½ÅÀç¼ö ¹Ú»ç)ÀÇ ¼¼¼Ç3À» °³¼³, ÃÖ½ÅÁ¤º¸¸¦ »êÇÐ °£ÀÇ »ý»ýÇÏ°Ô ±³È¯ÇÒ ¼ö ÀÖ´Â ÀÚ¸®¸¦ ¸¸µé¾ú´Ù°í ¹àÇû´Ù.
(¼¼¼Ç1)
¢¹ ÀÌ°æ ±³¼ö (µ¿±¹´ëÇб³ ¾àÇаú)
“Innovative Drug Discovery via Open Innovation at OTRCID”
¢¹ ±èÀÍ¿¬ ±³¼ö (¿¬¼¼´ëÇб³ ¾àÇаú)
“Exploring Heterocycle World“
¢¹ ±è¼ºÇå ±³¼ö (´ë±¸Ã·º¹´ÜÁö)
“Pyrazinyl-piperazinyl-piperidine Scaffold as a Novel CXCR3 Chemokine Receptor Antagonist“
(¼¼¼Ç2)
¢¹ ÀÌö¹ü ±³¼ö (¼¿ï´ëÇб³ ÈÇаú)
“Evolution of free radical reactions of organohalides”
¢¹ ÇãÁ¤³ç ¹Ú»ç (Çѱ¹ÈÇבּ¸¿ø)
“Direct one-pot synthesis of diverse polycyclic heterocyclic scaffolds”
¢¹ °ÀºÁÖ ±³¼ö (°æÈñ´ëÇб³ ÀÀ¿ëÈÇаú)
“Fe catalyzed cyclization reactions: hydrofunctionalization and tandem cross-coupling reactions”